The role of interleukin-16 in eosinophilic chronic rhinosinusitis

European Archives of Oto-Rhino-Laryngology

Volumn 264, Issue 8, 2007, Pages 887-893

  Lackner, Andreas ^a   Raggam, Reinhard Bernd ^a   Stammberger, Heinz ^a   Beham, Alfred ^a   Braun, Hannes ^a   Kleinhappl, Barbara ^a   Buzina, Walter ^a   Kittinger, Clemens ^a   Reinisch, Sabine ^a   Berghold, Andrea ^a   Freudenschuss, Kurt ^a   Barth, Sonja ^a   Marth, Egon ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Chronic rhinosinusitis; Eosinophils; IL 16

Indexed keywords

EOSIN; FORMALDEHYDE; HEMATOXYLIN; IMMUNOGLOBULIN E; INTERLEUKIN 16; MESSENGER RNA;

ADULT; ARTICLE; CELL MIGRATION; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIC RHINOSINUSITIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NOSE MUCOSA; NOSE MUCUS; NOSE OBSTRUCTION; NOSE POLYP; NOSE SURGERY; PARANASAL SINUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; RHINOSINUSITIS; STAINING; TISSUE SECTION;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; BIOLOGICAL MARKERS; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; EOSINOPHILS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOGLOBULIN E; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MALE; MIDDLE AGED; NASAL MUCOSA; POLYMERASE CHAIN REACTION; RHINITIS; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX;

EID: 34347384805     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-007-0300-6     Document Type: Article

References (21)

1. Bachert C, Gevaert P, Holtappels G, Cuvelier C, Van Cauwenberge P (2000) Nasal polyposis: from cytokines to growth. Am J Rhinol 14:279-290
2. Bandeira-Melo C, Sugiyama K, Woods LJ, et al (2002) IL-16 Promotes leukotriene C4 and IL-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine-mediated signaling. J Immunol 168:4756-4763
3. Benninger MS, Ferguson BJ, Hadley JA, et al (2003) Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology and pathophysiology. Otolaryngol Head Neck Surg 129S:1-32
4. Blaschke V, Reich K, Blaschke S, Zipprich S, Neumann C (2000) Rapid quantitation of proinflammatory and chemoattractant cytokine expression in small tissue samples and monocyte-derived dendritic cells: validation of a new real-time RT-PCR technology. J Immunol Methods 246:79-90
5. Cheng G, Ueda T, Eda F, Arima M, Yoshida N, Fukuda T (2001) A549 Cells can express interleukin-16 and stimulate eosinophil chemotaxis. Am J Respir Cell Mol Biol 25:212-218
6. Cruikshank WW, Kornfeld H, Center DM (2000) Interleukin-16. J Leukoc Biol 67:757-766
7. Ferland C, Flamand N, Davoine F, Chakir J, Laviolette M (2004) IL-16 activates plasminogen-plasmin system and promotes human eosinophil migration into extracellular matrix via CCR3-chemokine-mediated signalling and by modulating CD4 eosinophil expression. J Immunol 173:4417-4424
8. Hamilos DL, Leung DYM, Wood R, et al (1995) Evidence for distinct cytokine expression in allergic versus non aöllergic chronic sinusitis. J Allergy Clin Immunol 96:537-544
9. Karaki M, Dobashi H, Kobayashi R, Tokuda M, Ishida T, Mori N (2005) Expression of interleukin-16 in allergic rhinitis. Int Arch Allergy Immunol 238:67-72
10. Katzenstein AL, Sale SR, Greenberger PA (1983) Allergic Aspergillus sinusitis: a newly recognized form of sinusitis. J Allergy Clin Immunol 72:89-93
11. Kountakis SE, Arango P, Bradley D, Wade ZK, Borish L (2004) Molecular and cellular staging for the severity of chronic rhinosinusitis. Laryngoscope 114:1895-1905
12. Laberge S, Durham SR, Ghaffer O, et al (1997) Expression of IL-16 in allergen-induced late-phase nasal responses and relation to topical glucocorticosteroid treatment. J Allergy Clin Immunol 100:569-574
13. Laberge S, Pinsonneault S, Varga EM, et al (2000) Increased expression of IL-16 immunoreactivity in bronchial mucosa after segmental allergen challenge in patients with asthma. J Allergy Clin Immunol 106:293-301
14. Lee CH, Lee KS, Rhee CO, Lee SO, Min YG (1999) Distribution of RANTES and IL-5 in allergic nasal mucosa and nasal polyps. Ann Otol Rhinol Laryngol 108:594-598
15. Meltzer EO, Hamilos DL, Hadley JA, et al (2004) Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol Suppl 114(6):155-211
16. Pullerits T, Lindén A, Malmhäll C, Lötvall J (2001) Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis. Allergy 56:871-877
17. Stordeur P, Poulin LF, Craciun L, Zhou L, Schandené L, Lavareille de A, Goriely S, Goldman M (2002) Cytokine mRNA quantification by real-time PCR. J Immunol Methods 259:55-64
18. Steiner E, Kleinhappl B, Gutschi A, Marth E (1998) Analysis of hsp 70 mRNA levels in HepG2 cells exposed to various metals differing in toxicity. Toxicol Lett 97:169-176
19. Taha RA, Laverge S, Hamid Q, Olivenstein R (2001) Increased expression of the chemo attractant cytokinese, monocyte chemotactic protein-4, and interleukin-16 in induced sputum in asthmatic patients. Chest 120:595-601
20. Takeno S, Hirakawa K, Ueda T, Furukida K, Osada R, Yajin K (2002) Nuclear faktor-kappa B activation in the nasal polyp epithelium: relationship to local cytokine gene expression. Laryngoscope 112:53-58
21. Yang M, Hogan SP, Mahalingam S, et al (2003) Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. J Allergy Clin Immunol 112:935-943